Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTScience In Every StepFeel confident knowing every step a Librela (bedinvetmab injection) treated dog takes is backed by science + Learn More